NCT02806882View on ClinicalTrials.gov

Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 29, 2015

Primary Completion Date

October 24, 2016

Study Completion Date

October 24, 2016

Conditions
MeningitisVentriculitis
Interventions
DRUG

Ceftaroline fosamil

600mg IV infusion

Trial Locations (1)

21079

CHU Dijon, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02806882 - Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF) | Biotech Hunter | Biotech Hunter